Justine O'Malley | Vice President, Corporate Affairs |
Mark Pruzanski | Chief Executive Officer |
Jerry Durso | Chief Operating Officer |
Sandip Kapadia | Chief Financial Officer |
Michael Yee | Jefferies |
Brian Abrahams | RBC Capital Markets |
Alethia Young | Cantor Fitzgerald |
Irina Margine | Cowen |
Steven Seedhouse | Raymond James |
Ross Weinreb | Goldman Sachs |
Navin Jacob | UBS |
Jay Olson | Oppenheimer |
Good morning ladies and gentlemen and thank you for joining the Intercept Pharmaceuticals' First Quarter 2019 Financial Results Conference Call. All participants are now in a listen-only mode.
Following the opening remarks, Intercept's Management will open the lines for a question-and-answer period. Please be advised that this call is being recorded at the company's request and a webcast of this call will be archived on the company's website for approximately two weeks. I would now like to introduce Justine O'Malley, Vice President, Corporate Affairs.